%0 Journal Article %T Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference. %A Kloske CM %A Belloy ME %A Blue EE %A Bowman GR %A Carrillo MC %A Chen X %A Chiba-Falek O %A Davis AA %A Paolo GD %A Garretti F %A Gate D %A Golden LR %A Heinecke JW %A Herz J %A Huang Y %A Iadecola C %A Johnson LA %A Kanekiyo T %A Karch CM %A Khvorova A %A Koppes-den Hertog SJ %A Lamb BT %A Lawler PE %A Guen YL %A Litvinchuk A %A Liu CC %A Mahinrad S %A Marcora E %A Marino C %A Michaelson DM %A Miller JJ %A Morganti JM %A Narayan PS %A Naslavsky MS %A Oosthoek M %A Ramachandran KV %A Ramakrishnan A %A Raulin AC %A Robert A %A Saleh RNM %A Sexton C %A Shah N %A Shue F %A Sible IJ %A Soranno A %A Strickland MR %A Tcw J %A Thierry M %A Tsai LH %A Tuckey RA %A Ulrich JD %A van der Kant R %A Wang N %A Wellington CL %A Weninger SC %A Yassine HN %A Zhao N %A Bu G %A Goate AM %A Holtzman DM %J Alzheimers Dement %V 0 %N 0 %D 2024 Jul 19 %M 39031528 %F 16.655 %R 10.1002/alz.13877 %X BACKGROUND: The apolipoprotein E gene (APOE) is an established central player in the pathogenesis of Alzheimer's disease (AD), with distinct apoE isoforms exerting diverse effects. apoE influences not only amyloid-beta and tau pathologies but also lipid and energy metabolism, neuroinflammation, cerebral vascular health, and sex-dependent disease manifestations. Furthermore, ancestral background may significantly impact the link between APOE and AD, underscoring the need for more inclusive research.
METHODS: In 2023, the Alzheimer's Association convened multidisciplinary researchers at the "AAIC Advancements: APOE" conference to discuss various topics, including apoE isoforms and their roles in AD pathogenesis, progress in apoE-targeted therapeutic strategies, updates on disease models and interventions that modulate apoE expression and function.
RESULTS: This manuscript presents highlights from the conference and provides an overview of opportunities for further research in the field.
CONCLUSIONS: Understanding apoE's multifaceted roles in AD pathogenesis will help develop targeted interventions for AD and advance the field of AD precision medicine.
CONCLUSIONS: APOE is a central player in the pathogenesis of Alzheimer's disease. APOE exerts a numerous effects throughout the brain on amyloid-beta, tau, and other pathways. The AAIC Advancements: APOE conference encouraged discussions and collaborations on understanding the role of APOE.